Cannabinoides
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (3)
2011
-
Minireview: Recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55
Molecular Endocrinology, Vol. 25, Núm. 11, pp. 1835-1848
2010
-
Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain
European Journal of Neuroscience, Vol. 31, Núm. 8, pp. 1414-1422
2001
-
Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues
European Journal of Pharmacology, Vol. 420, Núm. 2-3, pp. 123-131